SBW Life Sciences Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported negative sales was KRW 0.00001 million. Net income was KRW 706.98 million compared to KRW 618.04 million a year ago.

Basic earnings per share from continuing operations was KRW 4 compared to KRW 4 a year ago. Diluted earnings per share from continuing operations was KRW 4 compared to KRW 4 a year ago. Basic earnings per share was KRW 4 compared to KRW 4 a year ago.